Duopharma Biotech Berhad announced the cessation of Encik Muhammad Shukri Bin Ismail as Non Independent and Non Executive Alternate Director. Date of change: 20 March 2024, Age: 32, Reason: Ceased to be the Alternate Director to Puan Amizar Binti Mizuar following the resignation of Puan Amizar Binti Mizuar as Non-Independent Non-Executive Director of Duopharma Biotech Berhad. Qualifications: Degree, Accounting and Finance, The University of Warwick, United Kingdom, 2014.

Working experience and occupation: Encik Muhammad Shukri is presently the Assistant Vice President in Strategic Investments of Permodalan Nasional Berhad (?PNB?). He has served in various positions in PNB, including as an Associate in Research & Technology Analysis, Analyst in Corporate Services and Public Equity, Senior Analyst in Corporate Services and Public Equity and Manager of Strategic Investments from 2015 to 2023. Since 1 April 2023, he served as an Assistant Vice President in Strategic Investments of PNB.